Page last updated: 2024-10-27

fexofenadine and Pregnancy

fexofenadine has been researched along with Pregnancy in 4 studies

fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Research Excerpts

ExcerptRelevanceReference
"Fexofenadine hydrochloride is a frequently used drug for treatment of allergic conditions during pregnancy, but the fetal safety of fexofenadine use has not been well studied."7.96Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes. ( Andersen, JT; Andersson, NW; Torp-Pedersen, C, 2020)
"Fexofenadine hydrochloride is a frequently used drug for treatment of allergic conditions during pregnancy, but the fetal safety of fexofenadine use has not been well studied."3.96Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes. ( Andersen, JT; Andersson, NW; Torp-Pedersen, C, 2020)
"Fluoxetine, antidepressant widely-used during pregnancy, is a selective inhibitor for P-glycoprotein (P-gp)."3.96Chiral Discrimination of P-glycoprotein in Parturient Women: Effect of Fluoxetine on Maternal-Fetal Fexofenadine Pharmacokinetics. ( Cavalli, RC; Duarte, G; Lanchote, VL; Moisés, ECD; Moreira, FL; Nardotto, GHB; Pinto, L, 2020)
"Fexofenadine is a well-identified in vivo probe substrate of P-glycoprotein (P-gp) and/or organic anion transporting polypeptide (OATP)."1.62Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model. ( Bapat, P; Berger, H; de Carvalho Cavalli, R; de Lima Moreira, F; Koren, G; Lanchote, VL; Lubetsky, A; Pinto, L, 2021)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Pinto, LSR1
Vale, GTD1
Moreira, FL2
Marques, MP1
Coelho, EB1
Cavalli, RC2
Lanchote, VL3
Andersson, NW1
Torp-Pedersen, C1
Andersen, JT1
Pinto, L2
Nardotto, GHB1
Moisés, ECD1
Duarte, G1
Bapat, P1
de Lima Moreira, F1
Lubetsky, A1
de Carvalho Cavalli, R1
Berger, H1
Koren, G1

Other Studies

4 other studies available for fexofenadine and Pregnancy

ArticleYear
Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, May-15, Volume: 1145

    Topics: Adult; Anti-Allergic Agents; Chromatography, High Pressure Liquid; Female; Humans; Plasma; Pregnancy

2020
Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes.
    JAMA pediatrics, 2020, 08-01, Volume: 174, Issue:8

    Topics: Adult; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Infant, Newborn; I

2020
Chiral Discrimination of P-glycoprotein in Parturient Women: Effect of Fluoxetine on Maternal-Fetal Fexofenadine Pharmacokinetics.
    Pharmaceutical research, 2020, Jun-17, Volume: 37, Issue:7

    Topics: Adult; Antidepressive Agents, Second-Generation; ATP Binding Cassette Transporter, Subfamily B; Case

2020
Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
    Pharmaceutical research, 2021, Volume: 38, Issue:4

    Topics: Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Drug Interactions; Female; Fluoxeti

2021